Medical Isotope Production Without Highly Enriched Uranium (2009)

Chapter: 7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations

Previous Chapter: 6 Molybdenum-99/Technetium-99m Production Costs
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 90
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 91
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 92
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 93
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 94
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 95
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 96
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 97
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 98
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 99
Suggested Citation: "7 Conversion to LEU-Based Production of Molybdenum-99: Technical Considerations." National Research Council. 2009. Medical Isotope Production Without Highly Enriched Uranium. Washington, DC: The National Academies Press. doi: 10.17226/12569.
Page 100
Next Chapter: 8 Conversion to LEU-Based Production of Molybdenum-99: Regulatory Considerations
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.